JPH07116125B2 - Phenoxyalkylcarboxylic acid derivative and method for producing the same - Google Patents
Phenoxyalkylcarboxylic acid derivative and method for producing the sameInfo
- Publication number
- JPH07116125B2 JPH07116125B2 JP3891289A JP3891289A JPH07116125B2 JP H07116125 B2 JPH07116125 B2 JP H07116125B2 JP 3891289 A JP3891289 A JP 3891289A JP 3891289 A JP3891289 A JP 3891289A JP H07116125 B2 JPH07116125 B2 JP H07116125B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- integer
- atom
- oxygen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、強力な選択的ロイコトリエン拮抗作用を有
し、喘息等のアレルギー疾患の予防及び治療に有用であ
る新規なフェノキシアルキルカルボン酸誘導体、その中
間原料及びそれらの製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention has a novel selective phenoxyalkylcarboxylic acid derivative having a strong selective leukotriene antagonism and useful for the prevention and treatment of allergic diseases such as asthma. The intermediate material and the manufacturing method thereof.
アラキドン酸の5−リポキシゲナーゼ系の代謝物である
ロイコトリエン類(ロイコトリエンC4,D4,E4)は、気管
支喘息等の即時型アレルギー疾患の主要な原因物質と考
えられているSRS−A(Slow reacting substance of an
aphylaxis)の構成成分である。Leukotrienes (leukotrienes C 4 , D 4 , and E 4 ), which are metabolites of the 5-lipoxygenase system of arachidonic acid, are considered to be the main causative agents of immediate-type allergic diseases such as bronchial asthma. reacting substance of an
aphylaxis) is a component.
したがって、ロイコトリエン類に拮抗する薬物は、有用
な抗アレルギー剤として期待されるが、経口で有効な薬
物は少なく、現在までのところ実用化された例は報告さ
れていない。Therefore, drugs that antagonize leukotrienes are expected as useful antiallergic agents, but few drugs are orally effective, and no practical examples have been reported so far.
また、本発明化合物と類似の構造を有するものとしては
特開昭58-189137号の記載があるが、エーテル結合の化
合物であり本発明化合物のようにチオエーテル結合を有
するものではなく構造的に異なるものである。更に、そ
の類似化合物の生物活性は充分なものではなく、本発明
化合物に比べ、有用なものではない。Further, as a compound having a structure similar to that of the compound of the present invention, there is a description in JP-A-58-189137, but it is a compound having an ether bond and does not have a thioether bond as in the compound of the present invention, but has a structural difference It is a thing. Furthermore, the biological activity of the similar compound is not sufficient, and is not useful as compared with the compound of the present invention.
本発明者らは、ロイコトリエン類に拮抗する薬物に関し
て鋭意研究を重ねた結果、下記一般式[I]で表される
6位アセチルフェノキシアルキルカルボン酸誘導体が経
口投与において強力で選択的なロイコトリエン拮抗作用
を有することを見出し、さらに驚くべきことにモルモッ
トにおいて惹起した気道過敏を著明に抑制することを見
出し、本発明を完成した。The present inventors have conducted extensive studies on drugs that antagonize leukotrienes, and as a result, the 6-position acetylphenoxyalkylcarboxylic acid derivative represented by the following general formula [I] has a strong and selective leukotriene antagonism in oral administration. The present invention has been completed and the present invention was completed by further surprisingly finding that the respiratory tract hypersensitivity induced in guinea pigs is significantly suppressed.
[式中、R1は水素原子、メチル基又はエチル基を、mは
2〜5の整数を、nは3〜8の整数を、X1及びX2は同一
又は相異なって、硫黄原子,酸素原子,スルフィニル基
又はスルフォニル基を表すが、X1,X2は同時に酸素原子
ではない] 本発明によれば、一般式[I]の化合物は以下に述べる
経路により製造することができる。 [In the formula, R 1 is a hydrogen atom, a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 1 and X 2 are the same or different, and are a sulfur atom, It represents an oxygen atom, a sulfinyl group or a sulfonyl group, but X 1 and X 2 are not oxygen atoms at the same time.] According to the present invention, the compound of the general formula [I] can be produced by the route described below.
(1) 下記の一般式[Ia]である化合物は、一般式
[II]の化合物に一般式[III]の化合物を作用させる
ことにより製造することができる。(1) The compound of the following general formula [Ia] can be produced by reacting the compound of the general formula [II] with the compound of the general formula [III].
[式中、R2はメチル基又はエチル基を、mは2〜5の整
数を、nは3〜8の整数を、X1は硫黄原子、酸素原子、
スルフィニル基又はスルフォニル基を、X3は硫黄原子又
は酸素原子を表すが、X1,X3は同時に酸素原子ではな
い] 反応は、有機溶媒、例えばアセトン,メチルエチルケト
ン,ジエチルケトン又はジメチルホルムアミド等中で、
反応温度としては室温〜溶媒還流温度で行うことが好ま
しい。また無機塩基例えば炭酸カリウム又は炭酸ナトリ
ウム等の存在、更にヨウ化カリウムの添加も好ましい。 [In the formula, R 2 is a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 1 is a sulfur atom, an oxygen atom,
A sulfinyl group or a sulfonyl group, X 3 represents a sulfur atom or an oxygen atom, but X 1 and X 3 are not oxygen atoms at the same time] The reaction is carried out in an organic solvent such as acetone, methyl ethyl ketone, diethyl ketone or dimethylformamide. ,
The reaction temperature is preferably room temperature to solvent reflux temperature. It is also preferable to add an inorganic base such as potassium carbonate or sodium carbonate, and to add potassium iodide.
[式中、R2及びnは前述の通りであり、X3は硫黄原子又
は酸素原子を表す] [式中、m及びX1は前述の通りであり、Yはハロゲン原
子を表す] (2) 下記一般式[Ib]で表される化合物は、一般式
[IV]の化合物に式[V]の化合物を作用させることに
より製造することができる。 [In the formula, R 2 and n are as described above, and X 3 represents a sulfur atom or an oxygen atom.] [Wherein, m and X 1 are as described above, and Y represents a halogen atom] (2) The compound represented by the following general formula [Ib] is the same as the compound of the general formula [IV] in the formula [V]. It can be produced by reacting the compound of
[式中、R2はメチル基又はエチル基を、mは2〜5の整
数を、nは3〜8の整数を、X2は硫黄原子、酸素原子、
スルフィニル基又はスルフォニル基を、X3は硫黄原子又
は酸素原子を表すが、X2,X3は同時に酸素原子ではな
い] 反応は、有機溶媒、例えばアセトン,メチルエチルケト
ン,ジエチルケトン又はジメチルホルムアミド等中で、
反応温度としては室温〜溶媒還流温度で行うことが好ま
しい。また無機塩基例えば炭酸カリウム又は炭酸ナトリ
ウム等の存在、更にヨウ化カリウムの添加も好ましい。 [In the formula, R 2 is a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 2 is a sulfur atom, an oxygen atom,
A sulfinyl group or a sulfonyl group, X 3 represents a sulfur atom or an oxygen atom, but X 2 and X 3 are not oxygen atoms at the same time] The reaction is carried out in an organic solvent such as acetone, methyl ethyl ketone, diethyl ketone or dimethylformamide. ,
The reaction temperature is preferably room temperature to solvent reflux temperature. It is also preferable to add an inorganic base such as potassium carbonate or sodium carbonate, and to add potassium iodide.
[式中、R2,X2n及びmは前述の通りであり、Y1はハロ
ゲン原子を表す] [式中、X3は前述の通りである] (3) 下記一般式[IIa]で表される化合物は、一般
式[VI]の化合物に一般式[VII]の化合物を作用させ
た後、保護基を除去することにより製造することができ
る。 [In the formula, R 2 , X 2 n and m are as described above, and Y 1 represents a halogen atom] [Wherein X 3 is as described above] (3) The compound represented by the following general formula [IIa] is obtained by reacting the compound of the general formula [VI] with the compound of the general formula [VII], It can be produced by removing the protecting group.
[式中、R2、nは前記に同じ] 反応は、有機溶媒、例えばアセトン,メチルエチルケト
ン,ジエチルケトン又はジメチルホルムアミド中で、反
応温度としては室温〜溶媒還流温度で行うことが好まし
い。また無機塩基例えば炭酸カリウム又は炭酸ナトリウ
ム等の存在、更にヨウ化カリウムの添加も好ましい。 [Wherein R 2 and n are the same as above] The reaction is preferably carried out in an organic solvent such as acetone, methyl ethyl ketone, diethyl ketone or dimethylformamide at a reaction temperature of from room temperature to a solvent reflux temperature. It is also preferable to add an inorganic base such as potassium carbonate or sodium carbonate, and to add potassium iodide.
一般式[VI]の化合物中、チオール基の保護基としては
ジメチルアミノカルボニル基又はベンジル基等が挙げら
れる。In the compound of the general formula [VI], examples of the protecting group for the thiol group include a dimethylaminocarbonyl group and a benzyl group.
[式中、R3は保護基を表す] Y2-(CH2)nCOOR2 [VII] [式中、R2およびnは前記の通りであり、Y2はハロゲン
原子を表す] (4) 一般式[IIa]で表される化合物は、また、次
の工程により製造される。一般式[VI]の化合物に下記
の一般式[VIII]の化合物を作用させ、一般式[IX]と
する。 [In the formula, R 3 represents a protecting group] Y 2 -(CH 2 ) n COOR 2 [VII] [In the formula, R 2 and n are as described above, and Y 2 represents a halogen atom] (4 ) The compound represented by the general formula [IIa] is also produced by the following steps. The compound of the general formula [VI] is reacted with the compound of the following general formula [VIII] to give a general formula [IX].
Y3-(CH2)n-Y4 [VIII] [式中、nは前記の通りであり、Y3及びY4は同一又は相
異なるハロゲン原子を表す] [式中、R3、Y4及びnは前記の通りである] 反応は、有機溶媒、例えばアセトン,メチルエチルケト
ン,ジエチルケトン又はジメチルホルムアミド中で、反
応温度としては室温〜溶媒還流温度で行うことが好まし
い。ついで一般式[IX]で表される化合物にシアン化ナ
トリウムもしくはシアン化カリウムを作用させることに
より一般式[IXa]とする。Y 3 -(CH 2 ) n -Y4 [VIII] [wherein n is as described above, and Y 3 and Y 4 represent the same or different halogen atoms] [Wherein R 3 , Y 4 and n are as described above] The reaction may be carried out in an organic solvent such as acetone, methyl ethyl ketone, diethyl ketone or dimethylformamide at a reaction temperature of room temperature to a solvent reflux temperature. preferable. Then, the compound represented by the general formula [IX] is reacted with sodium cyanide or potassium cyanide to obtain the general formula [IXa].
[式中、R3及びnは前記の通りである] 反応は、有機溶媒、例えばジメチルスルホキシド又はジ
メチルホルムアミド中で、室温〜100℃の温度で行うこ
とが好ましい。さらに一般式[IXa]で表される化合物
を加水分解後アルコールによりエステル化することによ
り一般式[IIa]とする。ニトリルの加水分解は水酸化
ナトリウム又は水酸化カリウム水溶液が好ましく、エス
テル化はアルコール中触媒量の濃硫酸の存在下還流する
ことが好ましい。 [Wherein R 3 and n are as described above] The reaction is preferably carried out in an organic solvent such as dimethylsulfoxide or dimethylformamide at a temperature of room temperature to 100°C. Further, the compound represented by the general formula [IXa] is hydrolyzed and then esterified with an alcohol to obtain the general formula [IIa]. The hydrolysis of the nitrile is preferably sodium hydroxide or potassium hydroxide aqueous solution, and the esterification is preferably refluxed in the presence of a catalytic amount of concentrated sulfuric acid in an alcohol.
(5) 下記一般式[IVa]で表される化合物は、一般
式[IIa]の化合物に一般式[VIII′]の化合物を作用
させることにより製造することができる。(5) The compound represented by the following general formula [IVa] can be produced by reacting the compound of general formula [IIa] with the compound of general formula [VIII′].
[式中、R2、Y1、m及びnは前記に同じ] Y−(CH2)m−Y1 [VIII′] [式中、Y,Y1及びnは前記の通りである] 反応は、有機溶媒、例えばアセトン,メチルエチルケト
ン,ジエチルケトン又はジメチルホルムアミド中で、反
応温度としては室温〜溶媒還流温度で行うことが好まし
い。また、無機塩基例えば炭酸カリウム又は炭酸ナトリ
ウムの存在、更にヨウ化カリウムの添加も好ましい。 [Wherein R 2 , Y 1 , m and n are the same as above] Y-(CH 2 ) m -Y 1 [VIII'] [wherein Y, Y 1 and n are as described above] Reaction Is preferably carried out in an organic solvent such as acetone, methyl ethyl ketone, diethyl ketone or dimethylformamide at a reaction temperature of room temperature to solvent reflux temperature. The presence of an inorganic base such as potassium carbonate or sodium carbonate, and addition of potassium iodide is also preferable.
(6) 一般式[III]もしくは[IV]でそれぞれX1,X
2がスルフィニル基である化合物は下記の一般式[III
a],[IVa]で表される化合物を酸化することにより製
造される。(6) X 1 and X in the general formula [III] or [IV], respectively.
A compound in which 2 is a sulfinyl group is represented by the following general formula [III
It is produced by oxidizing a compound represented by a] or [IVa].
[式中、Yはハロゲン原子を、mは2〜5の整数を表
す] [式中、R2,Y,m及びnは前記に同じ] 典型的には、一般式[IIIa]又は[IVa]で表される化
合物に当量もしくは過剰の温和な酸化剤、例えばm−ク
ロル過安息香酸,過酸化水素水等をそれぞれ適当な溶
媒、例えば塩化メチレン,アルコール等中で作用させる
ことにより製造される。 [In the formula, Y represents a halogen atom, and m represents an integer of 2 to 5] [Wherein R 2 , Y, m and n are the same as above] Typically, an equivalent or excess mild oxidizing agent to the compound represented by the general formula [IIIa] or [IVa], for example, m-chloro It is produced by reacting perbenzoic acid, aqueous hydrogen peroxide and the like in a suitable solvent such as methylene chloride and alcohol.
(7) 一般式[III]もしくは[IV]でそれぞれX1,X
2がスルフィニル基である化合物は一般式[IIIa],[I
Va]で表される化合物に2倍量もしくはより過剰の
(6)と同様の温和な酸化剤を作用させることにより製
造される。(7) X 1 and X in the general formula [III] or [IV], respectively.
Compounds in which 2 is a sulfinyl group are represented by the general formulas [IIIa], [I
It is produced by reacting the compound represented by Va] with a mild oxidant similar to (6) in a double amount or in excess.
(8) 一般式[I]でR1がメチル基又はエチル基でX1
が酸素原子又はスルフォニル基でX2がスルフィニル基で
ある化合物及び一般式[I]でR1がメチル基又はエチル
基でX1がスルフィニル基でX2が酸素原子又はスルフォニ
ル基である化合物はそれぞれ下記の一般式[Ia′],
[Ib′]で表される化合物に当量もしくは過剰の(6)
と同様の温和な酸化剤を作用させることにより製造され
る。(8) In the general formula [I], R 1 is a methyl group or an ethyl group, X 1
Is an oxygen atom or a sulfonyl group and X 2 is a sulfinyl group and a compound of the general formula [I] in which R 1 is a methyl group or an ethyl group, X 1 is a sulfinyl group and X 2 is an oxygen atom or a sulfonyl group, respectively. The following general formula [Ia′],
An equivalent amount or excess (6) of the compound represented by [Ib']
It is produced by reacting a mild oxidizing agent similar to.
[式中、R2はメチル基又はエチル基を、mは2〜5の整
数を、nは3〜8の整数を、X4は酸素原子又はスルフォ
ニル基を表す] [式中、R2はメチル基又はエチル基を、mは2〜5の整
数を、nは3〜8の整数を、X4は酸素原子又はスルフォ
ニル基を表す] (9) 一般式[I]でR1がメチル基又はエチル基でX1
が酸素原子又はスルフォニル基でX2がスルフォニル基で
ある化合物及び一般式[I]でR1がメチル基又はエチル
基でX1がスルフォニル基でX2が酸素原子又はスルフォニ
ル基である化合物はそれぞれ一般式[Ia′],[Ib′]
で表される化合物に2倍量もしくはより過剰の(6)と
同様の温和な酸化剤を作用させることにより製造され
る。 [In the formula, R 2 represents a methyl group or an ethyl group, m represents an integer of 2 to 5, n represents an integer of 3 to 8, and X 4 represents an oxygen atom or a sulfonyl group] [In the formula, R 2 represents a methyl group or an ethyl group, m represents an integer of 2 to 5, n represents an integer of 3 to 8, and X 4 represents an oxygen atom or a sulfonyl group] (9) General formula [I ] And R 1 is a methyl group or an ethyl group, X 1
Is an oxygen atom or a sulfonyl group and X 2 is a sulfonyl group, and a compound of the general formula [I] in which R 1 is a methyl group or an ethyl group, X 1 is a sulfonyl group and X 2 is an oxygen atom or a sulfonyl group, respectively. General formula [Ia'], [Ib']
It is produced by reacting the compound represented by the formula (2) with a 2-fold amount or an excess amount of a mild oxidant similar to (6).
次に本発明を具体例によって説明するが、これらの例に
よって本発明が限定されるものではない。Next, the present invention will be described with reference to specific examples, but the present invention is not limited to these examples.
実施例1. 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)プロポキシ]
−2−プロピルフェノキシ]酪酸エチル 4−(6−アセチル−3−ヒドロキシ−2−プロピルフ
ェノキシ]酪酸エチル1.6g,ヨウ化カリウム0.5g,炭酸カ
リウム1.45g及びアセトン30mlの混合物を攪拌下加熱還
流しながら、(4−(3−ブロモプロピルチオ)−2−
ヒドロキシ−3−プロピルフェニル)エタノン1.9gをア
セトン10mlに溶解した溶液を滴下した。攪拌下に6時間
加熱還流したのち、無機物を別し、液を濃縮して、
残渣をシリカゲルカラムクロマトグラフィー(ベンゼ
ン:酢酸エチル=9:1)で分離精製し、結晶2.1g(72.4
%)を得た。この結晶をエタノールから再結晶すると、
無色結晶となる。融点65〜66℃。Example 1. 4-[6-acetyl-3-[3-(4-acetyl-3-
Hydroxy-2-propylphenylthio)propoxy]
2-Propylphenoxy]ethyl butyrate Ethyl 4-(6-acetyl-3-hydroxy-2-propylphenoxy]butyrate Ethyl 1.6 g, potassium iodide 0.5 g, potassium carbonate 1.45 g and acetone 30 ml A mixture was heated under reflux with stirring. While (4-(3-bromopropylthio)-2-
A solution prepared by dissolving 1.9 g of hydroxy-3-propylphenyl)ethanone in 10 ml of acetone was added dropwise. After heating and refluxing for 6 hours with stirring, inorganic substances are separated, the liquid is concentrated,
The residue was separated and purified by silica gel column chromatography (benzene:ethyl acetate=9:1) to give 2.1 g of crystals (72.4
%) was obtained. When this crystal is recrystallized from ethanol,
It becomes colorless crystals. Melting point 65-66°C.
元素分析値(%):C31H42O7Sとして計算値 (実測値) C:66.64(66.53) H: 7.58( 7.72) 実施例2〜7 実施例1と同様にして表1に示した化合物を合成した。Elemental analysis value (%): Calculated value as C 31 H 42 O 7 S (measured value) C: 66.64 (66.53) H: 7.58 (7.72) Examples 2 to 7 The same as Example 1 and shown in Table 1. The compound was synthesized.
実施例8 4−[6−アセチル−3−[2−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)エトキシ]−
2−プロピルフェノキシ]酪酸エチル 4−(6−アセチル−3−(2−クロロエトキシ)−2
−プロピルフェノキシ)酪酸エチル0.60g、(2−ヒド
ロキシ−4−メルカプト−3−プロピルフェニル)エタ
ノン0.51g,ヨウ化カリウム0.1g,炭酸カリウム0.65g及び
アセトン40mlの混合物を攪拌下に19時間加熱還流した。
冷却後、無機物を別し、液を濃縮して、残渣をシリ
カゲルカラムクロマトグラフィー(ベンゼン:酢酸エチ
ル=15:1次いで9:1)で分離精製し、褐色油として目的
物0.73g(82.8%)を得た。 Example 8 4-[6-acetyl-3-[2-(4-acetyl-3-
Hydroxy-2-propylphenylthio)ethoxy]-
2-Propylphenoxy]ethyl butyrate 4-(6-acetyl-3-(2-chloroethoxy)-2
-Propylphenoxy) ethyl butyrate 0.60 g, (2-hydroxy-4-mercapto-3-propylphenyl)ethanone 0.51 g, potassium iodide 0.1 g, potassium carbonate 0.65 g and acetone 40 ml were heated to reflux with stirring for 19 hours. did.
After cooling, the inorganic substances were separated, the liquid was concentrated, and the residue was separated and purified by silica gel column chromatography (benzene:ethyl acetate=15:1 then 9:1) to give 0.73 g (82.8%) of the desired product as a brown oil. Got
元素分析値(%):C30H40O7Sとして 計算値(実測値) C:66.15(66.12) H: 7.40( 7.50) 実施例9,10 実施例8と同様にして表2に示した化合物を合成した。Elemental analysis value (%): Calculated value (measured value) as C 30 H 40 O 7 S C: 66.15 (66.12) H: 7.40 (7.50) Examples 9 and 10 The results are shown in Table 2 in the same manner as in Example 8. The compound was synthesized.
実施例11. 4−[6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)酪酸エチル (i) 4−(N,N−ジメチルカルバモイルチオ)−2
−ヒドロキシ−3−プロピルフェニル)エタノン26.6g,
4−ブロモ酪酸エチル92.2g,ヨウ化カリウム1g,炭酸カリ
ウム26.1g及びアセトン200mlの混合物を攪拌下に加熱還
流した。炭酸カリウム13gを9時間後及び14時間後にそ
れぞれ加え、合計29時間攪拌下加熱還流した後、無機物
を過し、溶媒を減圧濃縮した。残渣をシリカゲルカラ
ムクロマトグラフィー(ヘキサン次いでベンゼン最後に
ベンゼン:酢酸エチル=9:1にて溶出)で精製して淡褐
色結晶として4−(6−アセチル−3−(N,N−ジメチ
ルカルバモイルチオ)−2−プロピルフェノキシ)酪酸
エチル31.5g(84.2%)を得た。 Example 11. Ethyl 4-[6-acetyl-3-mercapto-2-propylphenoxy)butyrate (i) 4-(N,N-dimethylcarbamoylthio)-2
-Hydroxy-3-propylphenyl)ethanone 26.6 g,
A mixture of 92.2 g of ethyl 4-bromobutyrate, 1 g of potassium iodide, 26.1 g of potassium carbonate and 200 ml of acetone was heated to reflux with stirring. 13 g of potassium carbonate was added after 9 hours and 14 hours, respectively, and the mixture was heated under reflux for 29 hours with stirring, then the inorganic substances were passed through and the solvent was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane and then benzene and finally eluted with benzene:ethyl acetate=9:1) to give 4-(6-acetyl-3-(N,N-dimethylcarbamoylthio) as light brown crystals. 31.5 g (84.2%) of ethyl-2-propylphenoxy)butyrate was obtained.
融点60〜63℃ 元素分析値:C20H29NO5Sとして 計算値(実施値) C:60.74(60.89) H: 7.39( 7.58) N: 3.54( 3.38) (ii) 4−(6−アセチル−3−(N,N−ジメチルカ
ルバモイルチオ)−2−プロピルフェノキシ)酪酸エチ
ル10.6g,水酸化カリウム4.5g及びエタノール100mlを混
合し、1.5時間還流下に加熱攪拌した。氷水,濃塩酸を
加え(pH1)、酢酸エチルで抽出した。有機層を水,食
塩水で洗浄したのち、硫酸ナトリウムにて乾燥、減圧濃
縮した。残渣にエタノール30ml,濃硫酸0.5mlを加え、1.
5時間還流下に加熱攪拌した。氷水を加え、酢酸エチル
で抽出、有機層を水洗したのち、硫酸ナトリウムにて乾
燥、減圧濃縮した。褐色油状物として4−(6−アセチ
ル−3−メルカプト−2−プロピルフェノキシ)酪酸エ
チル7.8g(89.7%)を得た。′ H−NMR(CDCl3)δ:1.03(3H,t,J=7Hz,-CH2CH2 C
H3 ),1.28(3H,t,J=7Hz,CO2CH2 CH3 ),1.57(2H,m,-CH2
CH2 CH3),2.12(2H,m,-OCH2 CH2 CH2COOEt),2.5(2H,m,-
CH2 CO2Et),2.57(3H,s,COCH3),2.6(2H,m,-CH2 CH2C
H3),3.78(2H,t,J=6Hz,-OCH2 CH2CH2CO2Et),4.16(2
H,q,J=7Hz,CO2 CH2 CH3),7.10(1H,d,J=8Hz, 実施例12. 5−(6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)ペンタン酸エチル 実施例11と同様にして褐色油状物として定量的に目的物
を得た。′ H−NMR(CDCl3)δ:1.03(3H,t,J=7Hz,-CH2CH2 C
H3 ),1.27(3H,t,J=7Hz,−CO2CH2 CH3 ),1.57(2H,m,-C
H2 CH2 CH3),1.8(4H,m,-OCH2 CH2 CH2 CH2CO2Et),2.39(2
H,m,CH2 CO2Et),2.57(3H,s,COCH3),2.70(2H,m,-CH2 C
H2CH3),3.75(2H,m,-OCH2 (CH2)3CO2Et),4.14(2H,q,J
=7Hz,CO2 CH2 CH3),7.10(1H,d,J=8Hz, 実施例13. 6−(6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)ヘキサン酸エチル 実施例11と同様にして褐色油状物として収率69.0%で目
的物を得た。′ H−NMR(CDCl3)δ:1.02(3H,t,J=7Hz,-CH2CH2 C
H3 ),1.26(3H,t,J=7Hz,−CO2CH2 CH3 ),1.66(8H,m,-C
H2 CH2 CH3及び-OCH2 CH2 CH2 CH2 CH2CO2Et),2.34(2H,t,J
=7Hz,-CH2 CO2Et),2.57(3H,s,COCH3),2.60(2H,m,-C
H2 CH2CH3),3.73(2H,t,J=6Hz,-OCH2 (CH2)4CO2Et),4.
13(2H,q,J=7Hz,CO2 CH2 CH3),7.10(1H,d, 実施例14. 7−(6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)ヘプタン酸エチル (i) (4−(N,N−ジメチルカルバモイルチオ)−
2−ヒドロキシ−3−プロピルフェニル)エタノン5.8
g,1,6−ジブロモヘキサン25g,ヨウ化カリウム1g,炭酸カ
リウム5.7g及びアセトン40mlの混合物を還流下に加熱攪
拌した。炭酸カリウム2.9gを9.5時間後、20時間後及び3
0.5時間後にそれぞれ加え計41時間還流した。冷却後無
機物を過し、溶媒を減圧濃縮した。残渣をシリカゲル
カラムクロマトグラフィー(ベンゼン:ヘキサン=1:1
次いでベンゼン:酢酸エチル=9:1)で精製して褐色油
状物として7.3g(79.7%)の(2−(6−ブロモヘキシ
ルオキシ)−4−(N,N−ジメチルカルバモイルチオ)
−3−プロピルフェニル)エタノンを得た。′ H−NMR(CDCl3)δ:0.99(3H,t,J=7Hz,-CH2CH2 C
H3 ),1.2〜1.8(10H,m,-CH2 CH2 CH3及び-OCH2 CH2 CH2 CH2 C
H2 CH2Br),2.59(3H,s,COCH3),2.70(2H,m,-CH2 CH2C
H3),3.08(6H,s,-N(CH3 )2),3.35(2H,t,J=6Hz,-CH2 B
r),3.77(2H,t,J=6Hz,-OCH2 (CH2)5Br),7.30(2H,m, (ii) シアン化ナトリウム0.89gをジメチルスルホキ
シド20ml中に加え約50℃まで加温し、(2−(6−ブロ
モヘキシルオキシ)−4−(N,N−ジメチルカルバモイ
ルチオ)−3−プロピルフェニル)エタノン7.3gをジメ
チルスルホキシド40mlに溶解した溶液を約50〜60℃で攪
拌下に滴下した。さらに15分間90℃に反応させた後、氷
水に注ぎ酢酸エチルで抽出、有機層を水洗、硫酸ナトリ
ウムで乾燥し、減圧濃縮した。残渣をシリカゲルカラム
クロマトグラフィー(ベンゼン:酢酸エチル=9:1次い
で7:3)で精製して褐色油状物として4.4g(68.6%)の
7−(6−アセチル−3−(N,N−ジメチルカルバモイ
ルチオ)−2−プロピルエノキシ)ヘプタンニトリルを
得た。′ H−NMR(CDCl3)δ:0.99(3H,,J=7Hz,-CH2CH2 C
H3 ),1.3〜2.0(10H,m,-CH2 CH2 CH3及び-OCH2 CH2 CH2 CH2 C
H2 CH2CN),2.36(2H,m,-OCH2CH2CH2CH2CH2 CH2 CN),2.59
(3H,s,-COCH3 ),2.8付近(2H,m,-CH2 CH2CH3),3.08(6
H,s,(CH3 )2NCOS−),3.77(2H,t,J=6Hz,-OCH2 CH2CH2CH
2CH2CH2CN),7.32(2H,s, (iii) 7−(6−アセチル−3−(N,N−ジメチルカ
ルバモイルチオ)−2−プロピルフェノキシ)ヘプタン
ニトリル4.4g,水酸化カリウム1.9g,エタノール30mlの混
合物を1.5時間還流下に加熱攪拌した後減圧濃縮した。
残渣に氷水、次いで濃塩酸を加え酸性とし酢酸エチルに
て抽出した。有機層を水及び食塩水で洗浄した後、無水
硫酸ナトリウムで乾燥、減圧濃縮して褐色油状物3.7gを
得た。前記褐色油状物2.0g,水酸化カリウム2.0g、水20m
lの混合物を3時間還流下に加熱攪拌した後減圧濃縮し
た。残渣に氷水次いで濃塩酸を加え酸性とし酢酸エチル
にて抽出した。有機層を水洗次いで硫酸マグネシウムに
て乾燥し、減圧濃縮した。残渣に濃硫酸0.5mlエタノー
ル20mlを加えさらに1.5時間還流した。氷水を加え、酢
酸エチルで抽出、有機層を水及び食塩水で洗浄したの
ち、硫酸ナトリウムで乾燥、減圧濃縮した。褐色油状物
として1.8g(78.4%)の7−(6−アセチル−3−メル
カプト−2−プロピルフェノキシ)ヘプタン酸エチルを
得た。′ H−NMR(CDCl3)δ:1.02(3H,t,J=7Hz,-CH2CH2 C
H3 ),1.26(3H,t,J=7Hz,-CO2CH2 CH3 ),1.2〜2.0(10H,
m,CH2 CH2 CH3及び-OCH2 CH2 CH2 CH2 CH2 CH2CO2Et),2.31(2
H,m,-CH2 CO2Et),2.57(3H,s,COCH3),2.6付近(2H,m,-
CH2 CH2CH3),3.72(2H,t,J=6Hz,-CH2 (CH2)5CO2Et),4.
12(2H,q,J=7Hz,-CO2 CH2 CH3),7.01(1H,d,J=8Hz, 実施例15 9−(6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)ノナン酸エチル 実施例14と同様にして褐色油状物として総収率67.3%で
目的物を得た。′ H−NMR(CDCl3)δ:1.03(3H,t,J=7Hz,-CH2CH2 C
H3 ),1.26(3H,t,J=7Hz,-CO2CH2 CH3 ),1.2〜2.0(14H,
m,-CH2 CH2 CH3及び-OCH2 CH2 CH2 CH2 CH2 CH2 CH2 CH2CO2Et),
2.30(2H,t,J=7Hz,-CH2 CO2Et),2.58(3H,s,COCH3),
2.60付近(2H,m,-CH2 CH2CH3),3.72(2H,t,J=7Hz,-OCH
2 (CH2)7CO2Et),4.12(2H,q,J=7Hz,CO2 CH2 CH3),7.01
(1H,d,J=8Hz, 実施例16 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)プロピルチ
オ]−2−プロピルフェノキシ]酪酸エチル 4−(6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)酪酸エチル2.0g、(4−(3−ブロモプロピ
ルチオ)−2−ヒドロキシ−3−プロピルフェニル)エ
タノン2.0g、ヨウ化カリウム0.5g、炭酸カリウム1.7g及
びアセトン40mlの混合物を還流下に9時間加熱攪拌し
た。冷却後無機物を別し、液を濃縮して残渣をシリ
カゲルカラムクロマトグラフィー(ベンゼン:酢酸エチ
ル=9:1)で分離精製し、黄色油として目的物1.8g(50.
8%)を得た。Melting point 60 to 63°C Elemental analysis value: Calculated value as C 20 H 29 NO 5 S (actual value) C: 60.74 (60.89) H: 7.39 (7.58) N: 3.54 (3.38) (ii) 4-(6-acetyl Ethyl-3-(N,N-dimethylcarbamoylthio)-2-propylphenoxy)butyrate (10.6 g), potassium hydroxide (4.5 g) and ethanol (100 ml) were mixed and stirred under reflux for 1.5 hours. Ice water and concentrated hydrochloric acid were added (pH 1), and the mixture was extracted with ethyl acetate. The organic layer was washed with water and brine, dried over sodium sulfate, and concentrated under reduced pressure. To the residue was added 30 ml of ethanol and 0.5 ml of concentrated sulfuric acid, and 1.
The mixture was heated and stirred under reflux for 5 hours. Ice water was added, the mixture was extracted with ethyl acetate, the organic layer was washed with water, dried over sodium sulfate, and concentrated under reduced pressure. 7.8 g (89.7%) of ethyl 4-(6-acetyl-3-mercapto-2-propylphenoxy)butyrate was obtained as a brown oil. ′ H-NMR(CDCl 3 ) δ:1.03 (3H,t,J=7Hz,-CH 2 CH 2 C
H 3 ),1.28 (3H,t,J=7Hz,CO 2 CH 2 CH 3 ),1.57 (2H,m,-CH 2
CH 2 CH 3 ),2.12 (2H,m,-OCH 2 CH 2 CH 2 COOEt),2.5 (2H,m,-
CH 2 CO 2 Et),2.57 (3H,s,COCH 3 ),2.6 (2H,m,- CH 2 CH 2 C
H 3 ),3.78 (2H,t,J=6Hz,-O CH 2 CH 2 CH 2 CO 2 Et),4.16 (2
H,q,J=7Hz, CO 2 CH 2 CH 3 ), 7.10 (1H,d,J=8Hz, Example 12. Ethyl 5-(6-acetyl-3-mercapto-2-propylphenoxy)pentanoate In the same manner as in Example 11, the target product was quantitatively obtained as a brown oil. ′ H-NMR(CDCl 3 ) δ:1.03 (3H,t,J=7Hz,-CH 2 CH 2 C
H 3 ),1.27 (3H,t,J=7Hz,-CO 2 CH 2 CH 3 ),1.57 (2H,m,-C
H 2 CH 2 CH 3 ),1.8 (4H,m,-OCH 2 CH 2 CH 2 CH 2 CO 2 Et),2.39 (2
H,m, CH 2 CO 2 Et),2.57 (3H,s,COCH 3 ),2.70 (2H,m,- CH 2 C
H 2 CH 3 ),3.75 (2H,m,-O CH 2 (CH 2 ) 3 CO 2 Et),4.14 (2H,q,J
= 7Hz, CO 2 CH 2 CH 3 ), 7.10 (1H, d, J = 8Hz, Example 13. Ethyl 6-(6-acetyl-3-mercapto-2-propylphenoxy)hexanoate In the same manner as in Example 11, the target product was obtained as a brown oil in a yield of 69.0%. ′ H-NMR(CDCl 3 ) δ:1.02 (3H,t,J=7Hz,-CH 2 CH 2 C
H 3 ),1.26 (3H,t,J=7Hz,-CO 2 CH 2 CH 3 ),1.66 (8H,m,-C
H 2 CH 2 CH 3 and -OCH 2 CH 2 CH 2 CH 2 CH 2 CO 2 Et), 2.34 (2H,t,J
=7Hz,- CH 2 CO 2 Et),2.57 (3H,s,COCH 3 ),2.60 (2H,m,- C
H 2 CH 2 CH 3), 3.73 (2H, t, J = 6Hz, -O CH 2 (CH 2) 4 CO 2 Et), 4.
13 (2H,q,J=7Hz, CO 2 CH 2 CH 3 ), 7.10 (1H,d, Example 14. Ethyl 7-(6-acetyl-3-mercapto-2-propylphenoxy)heptanoate (i) (4-(N,N-dimethylcarbamoylthio)-
2-hydroxy-3-propylphenyl)ethanone 5.8
A mixture of 25 g of g,1,6-dibromohexane, 1 g of potassium iodide, 5.7 g of potassium carbonate and 40 ml of acetone was heated and stirred under reflux. 2.9 g of potassium carbonate after 9.5 hours, 20 hours and 3
The mixture was added after 0.5 hours and refluxed for a total of 41 hours. After cooling, the inorganic substances were passed and the solvent was concentrated under reduced pressure. Silica gel column chromatography of the residue (benzene:hexane=1:1)
Then it was purified with benzene:ethyl acetate=9:1) to give 7.3 g (79.7%) of (2-(6-bromohexyloxy)-4-(N,N-dimethylcarbamoylthio) as a brown oil.
-3-Propylphenyl)ethanone was obtained. ′ H-NMR(CDCl 3 )δ:0.99(3H,t,J=7Hz,-CH 2 CH 2 C
H 3 ), 1.2 to 1.8 (10H,m,-CH 2 CH 2 CH 3 and -OCH 2 CH 2 CH 2 CH 2 C
H 2 CH 2 Br),2.59 (3H,s,COCH 3 ),2.70 (2H,m,- CH 2 CH 2 C
H 3 ),3.08 (6H,s,-N( CH 3 ) 2 ),3.35 (2H,t,J=6Hz,- CH 2 B
r), 3.77 (2H,t,J=6Hz, -O CH 2 (CH 2 ) 5 Br), 7.30 (2H,m, (Ii) Sodium cyanide (0.89 g) was added to dimethyl sulfoxide (20 ml) and heated to about 50° C. to obtain (2-(6-bromohexyloxy)-4-(N,N-dimethylcarbamoylthio)-3-propylphenyl. ) A solution of 7.3 g of ethanone dissolved in 40 ml of dimethyl sulfoxide was added dropwise at about 50-60°C with stirring. After reacting at 90° C. for 15 minutes, the mixture was poured into ice water and extracted with ethyl acetate. The organic layer was washed with water, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (benzene:ethyl acetate=9:1 then 7:3) to give 4.4 g (68.6%) of 7-(6-acetyl-3-(N,N-dimethyl) as a brown oil. Carbamoylthio)-2-propylenoxy)heptanenitrile was obtained. ′ H-NMR (CDCl 3 ) δ:0.99 (3H,,J=7Hz,-CH 2 CH 2 C
H 3 ), 1.3 to 2.0 (10H,m,-CH 2 CH 2 CH 3 and -OCH 2 CH 2 CH 2 CH 2 C
H 2 CH 2 CN), 2.36 (2H,m,-OCH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CN), 2.59
(3H,s,-CO CH 3 ), around 2.8 (2H,m,- CH 2 CH 2 CH 3 ), 3.08 (6
H,s,( CH 3 ) 2 NCOS−), 3.77 (2H,t,J=6Hz,-O CH 2 CH 2 CH 2 CH
2 CH 2 CH 2 CN), 7.32 (2H,s, (Iii) A mixture of 7-(6-acetyl-3-(N,N-dimethylcarbamoylthio)-2-propylphenoxy)heptanenitrile 4.4 g, potassium hydroxide 1.9 g, and ethanol 30 ml was heated and stirred under reflux for 1.5 hours. After that, it was concentrated under reduced pressure.
Ice water and then concentrated hydrochloric acid were added to the residue to make it acidic, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give a brown oil (3.7 g). 2.0 g of the brown oil, 2.0 g of potassium hydroxide, 20 m of water
The mixture (1) was heated and stirred under reflux for 3 hours and then concentrated under reduced pressure. Ice water and then concentrated hydrochloric acid were added to the residue to acidify it, and the mixture was extracted with ethyl acetate. The organic layer was washed with water, dried over magnesium sulfate, and concentrated under reduced pressure. 0.5 ml of concentrated sulfuric acid and 20 ml of ethanol were added to the residue, and the mixture was further refluxed for 1.5 hours. Ice water was added, the mixture was extracted with ethyl acetate, the organic layer was washed with water and brine, dried over sodium sulfate, and concentrated under reduced pressure. 1.8 g (78.4%) of ethyl 7-(6-acetyl-3-mercapto-2-propylphenoxy)heptanoate was obtained as a brown oil. ′ H-NMR(CDCl 3 ) δ:1.02 (3H,t,J=7Hz,-CH 2 CH 2 C
H 3), 1.26 (3H, t, J = 7Hz, -CO 2 CH 2 CH 3), 1.2~2.0 (10H,
m,CH 2 CH 2 CH 3 and -OCH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO 2 Et), 2.31 (2
H,m,- CH 2 CO 2 Et), 2.57 (3H,s,COCH 3 ), around 2.6 (2H,m,-
CH 2 CH 2 CH 3 ), 3.72 (2H,t,J=6Hz,- CH 2 (CH 2 ) 5 CO 2 Et), 4.
12 (2H,q,J=7Hz,-CO 2 CH 2 CH 3 ), 7.01 (1H,d,J=8Hz, Example 15 Ethyl 9-(6-acetyl-3-mercapto-2-propylphenoxy)nonanoate In the same manner as in Example 14, the target product was obtained as a brown oil in a total yield of 67.3%. ′ H-NMR(CDCl 3 ) δ:1.03 (3H,t,J=7Hz,-CH 2 CH 2 C
H 3), 1.26 (3H, t, J = 7Hz, -CO 2 CH 2 CH 3), 1.2~2.0 (14H,
m,-CH 2 CH 2 CH 3 and -OCH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CO 2 Et),
2.30 (2H,t,J=7Hz,- CH 2 CO 2 Et), 2.58 (3H,s,COCH 3 ),
Near 2.60 (2H,m,- CH 2 CH 2 CH 3 ), 3.72 (2H,t,J=7Hz,-O CH
2 (CH 2 ) 7 CO 2 Et), 4.12 (2H,q,J=7Hz, CO 2 CH 2 CH 3 ),7.01
(1H,d,J=8Hz, Example 16 4-[6-acetyl-3-[3-(4-acetyl-3-
Ethyl hydroxy-2-propylphenylthio)propylthio]-2-propylphenoxy]butyrate 2.0 g Ethyl 4-(6-acetyl-3-mercapto-2-propylphenoxy)butyrate, (4-(3-Bromopropylthio)- A mixture of 2.0 g of 2-hydroxy-3-propylphenyl)ethanone, 0.5 g of potassium iodide, 1.7 g of potassium carbonate and 40 ml of acetone was heated and stirred under reflux for 9 hours. After cooling, the inorganic substances were separated, the liquid was concentrated, and the residue was separated and purified by silica gel column chromatography (benzene:ethyl acetate=9:1) to give 1.8 g (50.
8%).
元素分析値(%):C31H42O6S2として 計算値(実測値) C:64.78(64.66) H: 7.36( 7.38) 実施例17〜22 実施例16と同様にして表3に示した化合物を合成した。Elemental analysis value (%): Calculated value (measured value) as C 31 H 42 O 6 S 2 C:64.78 (64.66) H: 7.36 (7.38) Examples 17 to 22 Shown in Table 3 as in Example 16. Compounds were synthesized.
実施例23 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェノキシ)プロピルチオ]
−2−プロピルフェノキシ]酪酸エチル 4−(6−アセチル−3−メルカプト−2−プロピルフ
ェノキシ)酪酸エチル1.7g、(4−(3−ブロモプロポ
キシ)−2−ヒドロキシ−3−プロピルフェニル)エタ
ノン1.7g、ヨウ化カリウム0.5g、炭酸カリウム1.45g及
びアセトン40mlの混合物を還流下に7.5時間加熱攪拌し
た。氷水、濃塩酸を加え酢酸エチルで抽出した。水洗
後、芒硝で乾燥、減圧濃縮して残渣をシリカゲルカラム
クロマトグラフィー(ベンゼン:酢酸エチル=9:1)で
分離精製し、淡黄色結晶として目的物2.08g(71.0%)
を得た。融点87-88℃。 Example 23 4-[6-acetyl-3-[3-(4-acetyl-3-
Hydroxy-2-propylphenoxy)propylthio]
Ethyl-2-propylphenoxy]butyrate 1.7 g Ethyl 4-(6-acetyl-3-mercapto-2-propylphenoxy)butyrate, (4-(3-Bromopropoxy)-2-hydroxy-3-propylphenyl)ethanone 1.7 A mixture of g, 0.5 g of potassium iodide, 1.45 g of potassium carbonate and 40 ml of acetone was heated and stirred under reflux for 7.5 hours. Ice water and concentrated hydrochloric acid were added, and the mixture was extracted with ethyl acetate. After washing with water, drying over sodium sulfate and concentration under reduced pressure, the residue was separated and purified by silica gel column chromatography (benzene:ethyl acetate=9:1) to give 2.08 g (71.0%) of the desired product as pale yellow crystals.
Got Melting point 87-88°C.
元素分析値(%):C31H42O7Sとして 計算値(実測値) C:66.64(66.85) H: 7.58( 7.56) 実施例24 実施例23と同様にして表4に示した化合物を合成した。Elemental analysis value (%): Calculated value (measured value) as C 31 H 42 O 7 S C:66.64 (66.85) H: 7.58 (7.56) Example 24 The compounds shown in Table 4 were prepared in the same manner as in Example 23. Synthesized.
実施例31 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルスルフィニル)プロ
ポキシ]−2−プロピルフェノキシ]酪酸エチル 4−(6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)プロポキシ]
−2−プロピルフェノキシ]酪酸エチル1.2gを塩化メチ
レン40mlに溶解し、氷水浴下にm−クロロ過安息香酸0.
51gを加え、同温で2時間攪拌した。有機層を冷却した
炭酸カリウム水溶液で2回、次いで飽和食塩水で洗浄、
硫酸ナトリウムで乾燥し、濃縮した。残渣をシリカゲル
カラムクロマトグラフィー(ベンゼン:酢酸エチル=1:
1)で精製して無色結晶として目的物0.78g(63.2%)を
得た。 Example 31 4-[6-acetyl-3-[3-(4-acetyl-3-
Hydroxy-2-propylphenylsulfinyl)propoxy]-2-propylphenoxy]butyrate ethyl 4-(6-acetyl-3-[3-(4-acetyl-3-]
Hydroxy-2-propylphenylthio)propoxy]
1.2 g of ethyl-2-propylphenoxy]butyrate was dissolved in 40 ml of methylene chloride, and m-chloroperbenzoic acid of 0.
51 g was added, and the mixture was stirred at the same temperature for 2 hours. The organic layer was washed twice with a cooled aqueous solution of potassium carbonate and then with a saturated saline solution,
It was dried over sodium sulfate and concentrated. The residue was subjected to silica gel column chromatography (benzene: ethyl acetate = 1:
Purification in 1) gave 0.78 g (63.2%) of the desired product as colorless crystals.
融点74〜76℃ 元素分析値(%):C31H42O8Sとして 計算値(実測値) C:64.78(64.78) H: 7.37( 7.43) 実施例32 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルスルホニル)プロポ
キシ]−2−プロピルフェノキシ]酪酸エチル 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)プロポキシ]
−2−プロピルフェノキシ]酪酸エチル1.3gを塩化メチ
レン40mlに溶解し、氷水浴下にm−クロロ過安息香酸1.
05gを加え、同温で1時間攪拌した後、さらに室温で3
時間攪拌した。有機層を冷却した炭酸カリウム水溶液で
2回、次いで飽和食塩水で洗浄、硫酸ナトリウムで乾燥
し、濃縮した。残渣をシリカゲルカラムクロマトグラフ
ィー(ベンゼン:酢酸エチル=9:1次いで7:3)で精製し
て無色結晶として目的物0.97g(70.6%)を得た。Melting point 74-76°C Elemental analysis value (%): Calculated value (measured value) as C 31 H 42 O 8 S C:64.78 (64.78) H: 7.37 (7.43) Example 32 4-[6-acetyl-3-3 [3-(4-acetyl-3-
Hydroxy-2-propylphenylsulfonyl)propoxy]-2-propylphenoxy]ethyl butyrate 4-[6-acetyl-3-[3-(4-acetyl-3-]
Hydroxy-2-propylphenylthio)propoxy]
Ethyl-2-propylphenoxy]butyrate (1.3 g) was dissolved in methylene chloride (40 ml), and m-chloroperbenzoic acid (1.
After adding 05g and stirring at the same temperature for 1 hour, it was further stirred at room temperature for 3 hours.
Stir for hours. The organic layer was washed twice with cooled aqueous potassium carbonate solution, then with saturated brine, dried over sodium sulfate, and concentrated. The residue was purified by silica gel column chromatography (benzene:ethyl acetate=9:1 then 7:3) to obtain 0.97 g (70.6%) of the desired product as colorless crystals.
融点77〜79℃ 元素分析値(%):C31H42O9Sとして 計算値(実測値) C:63.03(63.11) H: 7.17( 7.19) 実施例33 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)プロポキシ]
−2−プロピルフェノキシ]酪酸 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェニルチオ)プロポキシ]
−2−プロピルフェノキシ]酪酸エチル2.1gをエタノー
ル10mlに溶解し、水酸化ナトリウム0.26gを水10mlに溶
解した溶液を加えた。湯浴上で5分間加熱した後、氷水
を加え冷却、塩酸を加え酸性とし酢酸エチルで抽出し
た。有機層を水洗、硫酸ナトリウムで乾燥し、濃縮し
た。残渣をシリカゲルカラムクロマトグラフィー(エタ
ノール:塩化メチレン=3:100)で分離精製して無色結
晶として目的物1.3g(65.2%)を得た。融点79〜81℃。
元素分析値(%):C29H38O7Sとして 計算値(実測値) C:65.64(65.81) H: 7.22( 7.24) 実施例34〜64 実施例33と同様にして表5に示した化合物を合成した。Melting point 77 to 79° C. Elemental analysis value (%): Calculated value as C 31 H 42 O 9 S (measured value) C: 63.03 (63.11) H: 7.17 (7.19) Example 33 4-[6-acetyl-3- [3-(4-acetyl-3-
Hydroxy-2-propylphenylthio)propoxy]
2-Propylphenoxy]butyric acid 4-[6-acetyl-3-[3-(4-acetyl-3-]
Hydroxy-2-propylphenylthio)propoxy]
2.1 g of ethyl-2-propylphenoxy]butyrate was dissolved in 10 ml of ethanol, and a solution of 0.26 g of sodium hydroxide in 10 ml of water was added. After heating on a hot water bath for 5 minutes, ice water was added and cooled, hydrochloric acid was added to acidify, and the mixture was extracted with ethyl acetate. The organic layer was washed with water, dried over sodium sulfate, and concentrated. The residue was separated and purified by silica gel column chromatography (ethanol:methylene chloride=3:100) to obtain 1.3 g (65.2%) of the desired product as colorless crystals. Melting point 79-81°C.
Elemental analysis value (%): Calculated value (measured value) as C 29 H 38 O 7 S C:65.64 (65.81) H: 7.22 (7.24) Examples 34 to 64 The results are shown in Table 5 in the same manner as in Example 33. The compound was synthesized.
実施例65 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェノキシ)プロピルスルフ
ィニル]−2−プロピルフェノキシ酪酸エチル 実施例31と同様にして淡黄色油状物として目的物を収率
81.0%で得た。 Example 65 4-[6-acetyl-3-[3-(4-acetyl-3-
Hydroxy-2-propylphenoxy)propylsulfinyl]-2-propylphenoxybutyrate ethyl In the same manner as in Example 31, the target product was obtained as a pale yellow oily substance.
Obtained at 81.0%.
元素分析値(%):C31H42O8Sとして 計算値(実測値) C:64.78(64.76) H: 7.37( 7.38) 実施例66 4−[6−アセチル−3−[3−(4−アセチル−3−
ヒドロキシ−2−プロピルフェノキシ)プロピルスルフ
ォニル]−2−プロピルフェノキシ酪酸エチル 実施例31と同様にして淡黄色油状物として目的物を収率
58.4%で得た。Elemental analysis value (%): Calculated value (measured value) as C 31 H 42 O 8 S C:64.78 (64.76) H: 7.37 (7.38) Example 66 4-[6-acetyl-3-[3-(4) -Acetyl-3-
Hydroxy-2-propylphenoxy)propylsulfonyl]-2-propylphenoxybutyrate ethyl In the same manner as in Example 31, the target compound was obtained in the form of a pale yellow oily substance.
Obtained at 58.4%.
元素分析値(%):C31H42O9Sとして 計算値(実測値) C:63.03(63.14) H: 7.17( 7.19) 実施例67 [4−(3−ブロモプロピルスフィニル]−2−ヒドロ
キシ−3−プロピルフェニル]エタノン 実施例31と同様にして淡黄色油状物として目的物を収率
55.2%で得た。Elemental analysis value (%): Calculated value (measured value) as C 31 H 42 O 9 S C: 63.03 (63.14) H: 7.17 (7.19) Example 67 [4-(3-Bromopropylsphinyl]-2- Hydroxy-3-propylphenyl]ethanone The target product was obtained as a pale yellow oil in the same manner as in Example 31.
Obtained in 55.2%.
マススペクトルm/z:346(M+),348(M++2) 実施例68 [4−(3−ブロモプロピルスルフォニル]−2−ヒド
ロキシ−3−プロピルフェニル]エタノン実施例32と同
様にして黄色油状物として目的物を収率63.4%で得た。Mass spectrum m/z: 346 (M + ), 348 (M + +2) Example 68 [4-(3-Bromopropylsulfonyl]-2-hydroxy-3-propylphenyl]ethanone Yellow as in Example 32. The target product was obtained as an oil in a yield of 63.4%.
マススペクトルm/z:362(M+),364(M++2) 実施例69〜71 実施例16及び31と同様にして表6に示した化合物を合成
した。Mass spectrum m/z: 362 (M + ), 364 (M + +2) Examples 69 to 71 In the same manner as in Examples 16 and 31, the compounds shown in Table 6 were synthesized.
〔発明の効果〕 実施例1.モルモット気道挟窄抑制試験 体重450g前後の雄性ハートレー(Hartley)系モルモッ
トをペントバルビタール・ナトリウム30mg/kg(腹腔
内)で麻酔し、気道内圧の変化をコンツェット−レスラ
ー変法(Konzett-Rossler;J.Harvey et al.,J.Pharmaco
l.Method.9,147-155,1983)に従って測定した。気道挟
窄反応は、ロイコトリエンD4(3μg/kg)を左外頚静脈
に挿入したカニューレより投与することにより惹起し
た。なお、ロイコトリエンD4投与に先立ち、動物にはイ
ンドメタシン及びプロプラノロールを静脈内投与した。
被験化合物は5%アラビアゴム溶液に懸濁し、ロイコト
リエンD4投与2時間前に経口投与した。実験結果を表7
に示した。 [Effect of the invention] Example 1. Guinea pig airway constriction inhibition test Male Hartley type guinea pigs with a body weight of about 450 g were anesthetized with pentobarbital sodium 30 mg/kg (intraperitoneal), and changes in airway pressure were detected by the konzet-wrestler. Modified method (Konzett-Rossler; J. Harvey et al., J. Pharmaco
l. Method. 9 , 147-155, 1983). The airway constriction reaction was induced by administering leukotriene D 4 (3 μg/kg) from a cannula inserted into the left external jugular vein. Prior to leukotriene D 4 administration, indomethacin and propranolol were intravenously administered to the animals.
The test compound was suspended in a 5% gum arabic solution and orally administered 2 hours before the administration of leukotriene D 4 . Table 7 shows the experimental results
It was shown to.
本発明は、モルモットの摘出回腸もしくは気管平滑筋標
本において強力なロイコトリエンD4拮抗作用を示し、更
に経口投与により低用量で気道挟窄抑制効果を示した。 The present invention showed a strong leukotriene D 4 antagonism in the isolated ileum of the guinea pig or the tracheal smooth muscle specimen, and further showed the effect of suppressing airway stenosis at a low dose by oral administration.
以上の成績から明らかなように、本発明化合物はロイコ
トリエン類が原因である疾病、例えば気管支喘息、目、
鼻及び胃腸のアレルギー性疾患やアレルギー性皮膚炎、
更に循環障害等の治療に有用である。As is clear from the above results, the compounds of the present invention are diseases caused by leukotrienes, such as bronchial asthma, eyes,
Nose and gastrointestinal allergic diseases and allergic dermatitis,
It is also useful for treating circulatory disorders and the like.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07C 319/02 319/14 323/22 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication C07C 319/02 319/14 323/22
Claims (12)
2〜5の整数を、nは3〜8の整数を、X1及びX2は同一
又は相異なって、硫黄原子、酸素原子、スルフィニル基
又はスルフォニル基を表すが、X1,X2は同時に酸素原子
ではない] で表されるフェノキシアルキルカルボン酸誘導体又はそ
れらのアルカリ塩。1. A general formula [I] [In the formula, R 1 is a hydrogen atom, a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 1 and X 2 are the same or different, and a sulfur atom, Represents an oxygen atom, a sulfinyl group or a sulfonyl group, but X 1 and X 2 are not oxygen atoms at the same time.] or an alkali salt thereof.
数を、X3は硫黄原子又は酸素原子を表す] で表される化合物に下記一般式[III] [式中、mは2〜5の整数を、Yはハロゲン原子を、X1
は硫黄原子、酸素原子、スルフィニル基又はスルフォニ
ル基を表すが、X3が酸素原子の場合はX1は酸素原子では
ない]で表される化合物を作用させることを特徴とす
る、下記一般式[Ia] [式中、R2はメチル基又はエチル基を、mは2〜5の整
数を、nは3〜8の整数を、X1は硫黄原子、酸素原子、
スルフィニル基又はスルフォニル基を、X3は硫黄原子又
は酸素原子を表すが、X1,X3は同時に酸素原子ではな
い] で表されるフェノキシアルキルカルボン酸誘導体の製造
方法。2. A general formula [II] [Wherein, R 2 represents a methyl group or an ethyl group, n represents an integer of 3 to 8 and X 3 represents a sulfur atom or an oxygen atom], and a compound represented by the following general formula [III] [In the formula, m is an integer of 2 to 5, Y is a halogen atom, X 1
Represents a sulfur atom, an oxygen atom, a sulfinyl group, or a sulfonyl group, but when X 3 is an oxygen atom, X 1 is not an oxygen atom]. Ia] [In the formula, R 2 is a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 1 is a sulfur atom, an oxygen atom,
A sulfinyl group or a sulfonyl group, X 3 represents a sulfur atom or an oxygen atom, but X 1 and X 3 are not oxygen atoms at the same time.].
子を、mは2〜5の整数を、nは3〜8の整数を、X2は
硫黄原子、酸素原子、スルフィニル基又はスルフォニル
基を表す] で表される化合物に下記一般式[V] [式中、X3は硫黄原子又は酸素原子を表すが、X2が酸素
原子の場合はX3は酸素原子ではない] で表される化合物を作用させることを特徴とする下記一
般式[Ib] [式中、R2はメチル基又はエチル基を、mは2〜5の整
数を、nは3〜8の整数を、X2は硫黄原子、酸素原子、
スルフィニル基又はスルフォニル基を、X3は硫黄原子又
は酸素原子を表すが、X2,X3は同時に酸素原子ではな
い] で表されるフェノキシアルキルカルボン酸誘導体の製造
方法。3. A general formula [IV] [In the formula, R 2 is a methyl group or an ethyl group, Y 1 is a halogen atom, m is an integer of 2 to 5, n is an integer of 3 to 8, and X 2 is a sulfur atom, an oxygen atom, or a sulfinyl group. Or a sulfonyl group] to the compound represented by the following general formula [V] [Wherein, X 3 represents a sulfur atom or an oxygen atom, but when X 2 is an oxygen atom, X 3 is not an oxygen atom]. The compound represented by the following general formula [Ib ] [In the formula, R 2 is a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 2 is a sulfur atom, an oxygen atom,
A sulfinyl group or a sulfonyl group, X 3 represents a sulfur atom or an oxygen atom, but X 2 and X 3 are not oxygen atoms at the same time.].
子を、nは3〜8の整数を表す]で表される化合物を作
用させた後、保護基を除去することを特徴とする、一般
式[IIa] [式中、R2、nは前記に同じ] で表される化合物の製造方法。4. General formula [VI] [Wherein R 3 represents a protecting group] and the following general formula [VII] Y 2 -(CH 2 ) n COOR 2 [VII] [wherein R 2 represents a methyl group or an ethyl group] , Y 2 is a halogen atom, and n is an integer of 3 to 8], and the protecting group is removed after the compound represented by the general formula [IIa]. [Wherein R 2 and n are the same as defined above].
nは3〜8の整数を表す] で表される化合物を作用させ一般式[IX] [式中、R3、Y4、nは前記に同じ] とした後、シアン化ナトリウムもしくはシアン化カリウ
ムによりシアノ化することにより一般式[IXa] とし、更に加水分解後アルコールによりエステル化及び
保護基を除去することを特徴とする、一般式[IIa] [式中、R2、nは前記に同じ] で表される化合物の製造方法。5. A general formula [VI] [Wherein R 3 represents a protecting group] and the following general formula [VIII] Y 3 -(CH 2 ) n -Y 4 [VIII] [wherein Y 3 and Y 4 are the same or in phase Different halogen atoms,
n represents an integer of 3 to 8] and a compound represented by the general formula [IX] [Wherein R 3 , Y 4 , and n are the same as those defined above] and then cyanated with sodium cyanide or potassium cyanide to give a compound of the general formula [IXa] In addition, after the hydrolysis, the esterification and the protecting group are removed by alcohol, and the general formula [IIa] [Wherein R 2 and n are the same as defined above].
を、mは2〜5の整数を表す] で表される化合物を作用させることを特徴とする、一般
式[IVa] [式中、R2、Y1、m及びnは前記に同じ] で表される化合物の製造方法6. A general formula [IIa] [Wherein R 2 and n are the same as above] and the following general formula [VIII′] Y—(CH 2 ) m —Y 1 [VIII′] [wherein Y and Y 1 are the same] Or a different halogen atom, m represents an integer of 2 to 5], a compound represented by the general formula [IVa] [Wherein R 2 , Y 1 , m and n are the same as defined above]
子を、mは2〜5の整数を、nは3〜8の整数を表す] で表される化合物を酸化することを特徴とする、一般式
[IV]でX2はスルフィニル基又はスルフォニル基である
化合物の製造方法。7. A general formula [IVa] [Wherein R 2 represents a methyl group or an ethyl group, Y 1 represents a halogen atom, m represents an integer of 2 to 5, and n represents an integer of 3 to 8]. A method for producing a compound having the general formula [IV], wherein X 2 is a sulfinyl group or a sulfonyl group.
す] で表される化合物を酸化することを特徴とする、一般式
[III]でX1がスルフィニル基又はスルフォニル基であ
る化合物の製造方法。8. A general formula [IIIa] [Wherein Y represents a halogen atom and m represents an integer of 2 to 5], and X 1 is a sulfinyl group or a sulfonyl group in the general formula [III], which is characterized by being oxidized. Method for producing compound.
数を、nは3〜8の整数を、X4は酸素原子又はスルフォ
ニル基を表す] で表される化合物を酸化することを特徴とする、一般式
[I]で、R2はメチル基又はエチル基、X1が酸素原子又
はスルフォニル基、X2がスルフィニル基又はスルフォニ
ル基である化合物の製造方法。9. A general formula [Ia′] [Wherein, R 2 represents a methyl group or an ethyl group, m represents an integer of 2 to 5, n represents an integer of 3 to 8, and X 4 represents an oxygen atom or a sulfonyl group]. In the formula [I], R 2 is a methyl group or an ethyl group, X 1 is an oxygen atom or a sulfonyl group, and X 2 is a sulfinyl group or a sulfonyl group.
数を、nは3〜8の整数を、X4は酸素原子又はスルフォ
ニル基を表す] で表される化合物を酸化することを特徴とする、一般式
[I]で、R2はメチル基又はエチル基、X1がスルフィニ
ル基又はスルフォニル基、X2が酸素原子又はスルフォニ
ル基である化合物の製造方法。10. A general formula [Ib′] [Wherein, R 2 represents a methyl group or an ethyl group, m represents an integer of 2 to 5, n represents an integer of 3 to 8, and X 4 represents an oxygen atom or a sulfonyl group]. Wherein R 2 is a methyl group or an ethyl group, X 1 is a sulfinyl group or a sulfonyl group, and X 2 is an oxygen atom or a sulfonyl group.
数を、nは3〜8の整数を、X1及びX3は同一又は相異な
って、硫黄原子、酸素原子、スルフィニル基又はスルフ
ォニル基を表すが、X1,X3は同時に酸素原子ではない] で表される化合物を加水分解することを特徴とする、一
般式[I]で、R1が水素原子である化合物の製造方法。11. General formula [Ia] [In the formula, R 2 is a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 1 and X 3 are the same or different, and are a sulfur atom, an oxygen atom, A sulfinyl group or a sulfonyl group, wherein X 1 and X 3 are not oxygen atoms at the same time] is hydrolyzed, and in the general formula [I], R 1 is a hydrogen atom. Method for producing compound.
2〜5の整数を、nは3〜8の整数を、X1及びX2は同一
又は相異なって、硫黄原子,酸素原子,スルフィニル基
又はスルフォニル基を表すが、X1,X2は同時に酸素原子
でない] で表される化合物又はその塩の少なくとも1種以上を有
効成分とする抗アレルギー剤。12. General formula [I] [In the formula, R 1 is a hydrogen atom, a methyl group or an ethyl group, m is an integer of 2 to 5, n is an integer of 3 to 8, X 1 and X 2 are the same or different, and are a sulfur atom, An oxygen atom, a sulfinyl group, or a sulfonyl group, but X 1 and X 2 are not oxygen atoms at the same time] or an antiallergic agent containing at least one compound thereof as an active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3891289A JPH07116125B2 (en) | 1988-03-07 | 1989-02-18 | Phenoxyalkylcarboxylic acid derivative and method for producing the same |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63-53374 | 1988-03-07 | ||
| JP5337488 | 1988-03-07 | ||
| JP3891289A JPH07116125B2 (en) | 1988-03-07 | 1989-02-18 | Phenoxyalkylcarboxylic acid derivative and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH021459A JPH021459A (en) | 1990-01-05 |
| JPH07116125B2 true JPH07116125B2 (en) | 1995-12-13 |
Family
ID=26378212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3891289A Expired - Lifetime JPH07116125B2 (en) | 1988-03-07 | 1989-02-18 | Phenoxyalkylcarboxylic acid derivative and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07116125B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060854B2 (en) * | 2003-06-24 | 2006-06-13 | Medicinova, Inc. | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid |
| US7064146B2 (en) * | 2003-06-24 | 2006-06-20 | Medicinova, Inc. | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| KR20070058381A (en) * | 2004-04-27 | 2007-06-08 | 메디시노바, 인크. | Phenoxyalkylcarboxylic acid derivatives for the treatment of inflammatory diseases |
| US20150321989A1 (en) * | 2014-05-08 | 2015-11-12 | Medicinova, Inc. | Method of treating idiopathic pulmonary fibrosis |
-
1989
- 1989-02-18 JP JP3891289A patent/JPH07116125B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH021459A (en) | 1990-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1242196A (en) | Leukotriene antagonists | |
| KR960007602B1 (en) | Phenoxyalkylcarboxylic acid derivatives and preparation method thereof | |
| HU198192B (en) | Process for producing new tetrazoles with leukotriene antagonist activity and pharmaceutical compositions comprising same | |
| JPS59128359A (en) | 1'-ethoxycarbonyloxyethyl ester of valproic acid, manufacture and antiepileptic drug | |
| US5292771A (en) | Substituted β-diketones and their use | |
| EP0094102B1 (en) | 1-(1-cyclohexanyl-methyl) pyrrolidine derivatives, and process for their preparation | |
| US4122194A (en) | Aryl sulphur compounds as antiasthmatics | |
| FR2621038A1 (en) | ALKADIAN DERIVATIVES, THEIR PREPARATIONS, MEDICAMENTS CONTAINING SAME AND INTERMEDIATE PRODUCTS | |
| JPH07116125B2 (en) | Phenoxyalkylcarboxylic acid derivative and method for producing the same | |
| EP0017543B1 (en) | Benzothiazole derivatives, process for their preparation and their therapeutical uses | |
| JPH02160A (en) | Di-t-butylphenol substituted by alkoxy, benzyloxy or benzylthio group | |
| JPS604177B2 (en) | Method for producing benzofuran derivatives | |
| EP0440324B1 (en) | Substituted beta-diketones and their use in the treatment of inflammatory bowel disease | |
| EP0005091B1 (en) | Monosubstituted piperazines, processes for their preparation and pharmaceutical compositions containing them | |
| US3948955A (en) | 4'-Carboxy-flavone | |
| JPS61268651A (en) | Phenylacetic acid derivative and production thereof | |
| JPH0819041B2 (en) | Phenoxyalkylcarboxylic acid derivative and method for producing the same | |
| US3758688A (en) | Substituted sulfonanilides in the treatment of inflammation | |
| KR960007084B1 (en) | Cyclic anthranilic acid acetic acid derivative, preparation method thereof and pharmaceutical agent containing same | |
| US4042708A (en) | Pharmaceutical compositions containing 4-carboxy-flavones | |
| JPH0420917B2 (en) | ||
| EP0057141B1 (en) | Esters of halogene-biphenylcarboxylates, method of preparation and their application as medicines | |
| FR2547726A1 (en) | 2- (4-BIPHENYL) -4-HEXENOIC ACID AND DERIVATIVES HAVING ANTI-INFLAMMATORY ACTIVITY | |
| GB1571829A (en) | Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds | |
| HU208418B (en) | Process for producing phenoxy derivative intermediates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071213 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081213 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081213 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091213 Year of fee payment: 14 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091213 Year of fee payment: 14 |